Nanoparticle-Based Combination Therapy
Led by Joseph Piepmeier, MD at Yale School of Medicine
Glioma Stem Cells (GSCs) have recently been identified as the likely root of glioma development, yet most current chemotherapy drugs cannot eliminate them. This study focuses on identifying drugs that can eliminate GSCs and using nanotechnology to deliver these drugs directly to the cells.
Click here for a full list of research grants funded by Voices Against Brain Cancer.